• 1
    First Australian Conference on Hepatitis C. Conference Proceedings Sydney 1997.
  • 2
    Farrell G. Acute viral hepatitis. Med J Aust 1998; 168:565570.
  • 3
    Farrell G. Chronic viral hepatitis. Med J Aust 1998;168:619626.
  • 4
    Shiell A., Briggs A., Farrell GC. The cost-effectiveness of alpha interferon in the treatment of chronic active hepatitis C. Med J Aust 1994;160:268272.
  • 5
    Alter MJ, Mast EE, Moyer LA, Margolis HS. Hepatitis C. Infect Dis Clin North Am 1998;12:1326.
  • 6
    Fotos P. Medical/dental management of a chronic hepatitis C patient. Oral Surg Oral med Oral Pathol 1993;75:786790.
  • 7
    Alter MJ, Moyer LA. The importance of preventing hepatitis C virus infection among injecting drug users in the United States. J Acquir Immune Defic Syndr Hum Retrovirol 1998;18(Suppl 1): S610.
  • 8
    Koike K., Moriya K., Ishibashi K., et al. Sialadenitis histologically resembling Sjögren syndrome in mice transgenic for hepatitis C virus envelope genes. Proc Natl Acad Sci USA 1997; 94:233236.
  • 9
    World Health Organization. Oral health surveys. Basic methods. 3rd edn. Geneva : World Health Organization, 1989.
  • 10
    Ainamo J., Barmes G., Beagrie G., Cutress T., Sardo-Infirri J. Development of the World Health Organization (WHO) Community Periodontal Index Treatment Needs (CPITN). Int Dent J 1972;32:279291.
  • 11
    Molinari JA. Hepatitis C virus infection. Dent Clin North Am 1996;40:308325.
  • 12
    Slade GD, Spencer AJ. Development and evaluation of the Oral Health Impact Profile. Community Dent Health 1994;11:311.
  • 13
    TenovuoJO, ed. Human saliva: Clinical chemistry and microbiology. Boca Raton : CRC Press, 1989.
  • 14
    Berg E., Tjell JC. Paraffin chewing as a saliva stimulating agent. J Dent Res 1969;48:325.
  • 15
    Brennan DS, Carter KD, Stewart JF, Spencer AJ. Commonwealth Dental Health Program evaluation report: 1994-96. Adelaide : AIHW Dental Statistics and Research Unit, University of Adelaide, 1997.
  • 16
    Denatal Statistics and Research Unit. Dental care for adults in Australia. Adelaide : AIHW Dental Statistics and Research Unit, University of Adelaide, 1993.
  • 17
    SAS Institute Inc. SAS/SAT User's guide. Cary : SAS Institute 1988.
  • 18
    Gorsky M., Raviv M., Moskona D., Laufer M., Bodner L. Clinical characteristics and treatment of patients with oral lichen planus in Israel. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1996;82:644649.
  • 19
    Carrozzo M., Gandolfo S., Carbone M., et al. Hepatitis C virus infection in Italian patients with oral lichen planus: a prospective case control study. J Oral Pathol Med 1996; 25:527533.
  • 20
    Coates E., Slade GD, Goss AN, Gorkic E. Oral conditions and their social impact among HIV dental patients. Aust Dent J 1996;41:3336.
  • 21
    Bonkovsky HL, Woolley JM. Reduction of health-related quality of life in chronic hepatitis C and improvement with interferon therapy. Hepatology 1999;29:264270.